High activity iodine 125 endocurietherapy for recurrent skull base tumors

Journal Article · Fri Apr 15 00:00:00 EDT 1988 · Cancer (Philadelphia); (United States)

DOI:https://doi.org/10.1002/1097-0142(19880415)61:8<1518::AID-CNCR2820610807>3.0.CO;2-D· OSTI ID:7241001

Kumar, P P; Good, R R; Leibrock, L G; Mawk, J R; Yonkers, A J; Ogren, F P

Experience with endocurietherapy of skull base tumors is reviewed. We present our cases of recurrent pituitary hemangiopericytoma, radiation-induced recurrent meningioma, recurrent clival chordoma, recurrent nasopharyngeal cancer involving the cavernous sinus, and recurrent parotid carcinoma of the skull base which were all successfully retreated with high-activity 125-iodine (I-125) permanent implantation.76 references.

• Research Organization: Univ. of Nebraska College of Medicine, Omaha (USA)
• OSTI ID: 7241001
• Journal Information: Cancer (Philadelphia); (United States), Vol. 61:8
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
NEOPLASMS
RADIOTHERAPY
SKULL
IODINE 125
RADIATION SOURCE IMPLANTS
REVIEWS
BETA DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
DOCUMENT TYPES
ELECTRON CAPTURE RADIOISOTOPES
IMPLANTS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
MEDICINE
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIATION SOURCES
RADIOISOTOPES
RADIOLOGY
SKELETON
THERAPY
550603* - Medicine- External Radiation in Therapy- (1980-)